Photo: Depositphotos
Jul 11, 2025, 07:44
New Lancet Seminar on the Latest in Management of Testicular Cancer
The Lancet Group shared a post on LinkedIn:
“Testicular cancer is the 20th most common type of cancer in males worldwide. However, it stands out as the most common solid tumour affecting young men aged 15–44 years.
In The Lancet, a new Seminar provides a detailed review to keep clinicians and researchers up to date with the latest in management.
Access the Seminar, and share with colleagues.”
The post also included a poll with the question:
“Approximately what percentage of testicular cancers are testicular germ cell tumours?”
The response options were:
- 75%
- 24%
- 95%
- 50%
Vote on the LinkedIn poll here.
Read More About Testicular Cancer on OncoDaily’s Special Article.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 11, 2025, 07:44
Jul 11, 2025, 07:19
Jul 11, 2025, 06:01